Objective To examine whether a lifestyle intervention in pregnancy limits gestational weight gain (GWG) and provides measurable health benefits for mother and newborn.
Introduction
Obesity has become a pressing public health issue around the globe. Although the aetiology is complex, there is no doubt about the role of over-nutrition and sedentary lifestyle in fuelling the epidemic. 1 Preventive efforts may be more effective than the treatment of individuals who are already overweight or obese, 2 and might be particularly timely in pregnancy, when two lives are affected. 3, 4 Observational studies show that large gestational weight gain (GWG) is associated with postpartum weight retention and with the development of obesity later in the mother's life. 5, 6 Excess GWG has been associated with complications of pregnancy, such as pre-eclampsia and gestational diabetes, [7] [8] [9] and with an increased incidence of caesarean section. 7, 10 For the child, large GWG is associated with an increased birthweight. 11, 12 Both large GWG and high birthweight are associated with an increased risk of obesity in childhood and adolescence. 13, 14 These observational studies have prompted a variety of trials of prenatal interventions to limit GWG through improving diet and/or increasing physical activity. Assessing the efficacy of interventions has been difficult, in part because of the heterogeneity of interventions and study populations, and because of the small size of most trials. 15, 16 There is now evidence that exercise interventions limit GWG, [15] [16] [17] [18] and may reduce the risk of gestational diabetes. 19 Interventions targeting diet alone have demonstrated a greater limitation of GWG, 15, 20 and a decreased risk of both gestational diabetes and pre-eclampsia. 15 Combining diet and exercise could potentially increase the intervention strength, but meta-analyses of combined/lifestyle interventions have shown less effect on GWG than dietary interventions alone, 15 and no effect on other pregnancy outcomes. 15, 21 To our knowledge, however, the published lifestyle interventions have provided counselling alone, with just two exceptions. 22, 23 Many women are reluctant to exercise, particularly in pregnancy, and providing exercise classes rather than counselling may improve compliance. 18 As excessive GWG is associated with an increased risk of obstetrical complications and postpartum weight retention for both women who are normal weight and women who are overweight, 7 ,24 a population-based health initiative to limit GWG should be suitable for women of all sizes. Many trials published to date have only included women who were overweight or obese. 18, 20, 23, 25, 26 The Norwegian Fit for Delivery (NFFD) intervention consists of dietary counselling and supervised exercise groups, and was designed to be feasible in a clinical setting for a general population and to be easily reproducible. The aim of the NFFD randomised trial was to examine whether the intervention resulted in measurable health benefits for both mother and infant. Here we report the effects of the intervention on GWG, newborn birthweight, obstetrical outcomes, and neonatal outcomes.
Methods

Study design and participants
The NFFD study is a randomised, blinded, controlled trial with two parallel groups performed in southern Norway, encompassing the cities of Kristiansand and Mandal, as well as the more rural surrounding areas. The protocol for the trial has already been published. 27 Midwives at eight healthcare clinics enrolled participants between September 2009 and February 2013. All healthcare clinics received the same information regarding study participation. Women were eligible if they were nulliparous, with a singleton pregnancy at ≤20 weeks of gestation, had a pre-pregnancy body mass index (BMI) of ≥19 kg/m 2 , were literate in Norwegian or English, and provided signed, informed consent. Exclusion criteria were pre-existing diabetes, disabilities precluding participation in a physical fitness programme (based on national and international recommendations), 28 continued substance abuse, or planned relocation outside of the study area before delivery. The first 20 participants comprised a feasibility study. The protocol was modified to include a lower age limit of 18 years and to allow randomisation after initial questionnaires and blood tests were completed, in order to ensure that the participants were sufficiently motivated and to avoid missing data. The Norwegian Regional Committee for Medical Research Ethics South-East-C approved the trial and modifications (REK reference 2009/429).
Participating clinics documented the attendance of 4245 women during the inclusion period. We approximate that 1610 were nulliparous (Figure 1 ), based on detailed data from four participating clinics.
Randomisation and blinding
After receiving signed consent forms and confirming that blood tests and questionnaires were completed, a research nurse assigned participants consecutively to the intervention or control arm of the study using a computer-generated list with 1 : 1 allocation ratio in blocks of 20. The research nurse never met the participants, had no role in recruitment or measurements, and had no knowledge of questionnaire responses. All examinations, blood test evaluations, record reviews, and scoring of questionnaire responses were performed by assessors blinded to group allocation.
Intervention
Details of the dietary and physical activity components of the NFFD, and the rationale behind them, were published previously. 27, 29 The dietary component consisted of ten recommendations designed to increase awareness of food choices, with specific advice on portion sizes, regular meal patterns, limiting the consumption of snack foods, and increasing the intake of water, fruits, and vegetables. Dietary counselling was performed by telephone, with an initial consultation and then a follow-up 4-6 weeks later, each of approximately 20 minutes. Counsellors were either experienced clinical dieticians or graduate students in public health who were trained and supervised by the NFFD team. Intervention participants were informed of the recommended GWG based on pre-pregnancy BMI and current Institute of Medicine (IOM) guidelines (GWG: normal weight, 11.5-16.0 kg; overweight, 7.0-11.5 kg; obese, 5.0-9.0 kg). 24 The physical activity component consisted of access to twice-weekly exercise classes at a local gym facil-ity, all following the same pattern: 10 minutes of warm-up, 40 minutes of strength training and cardiovascular exercise at moderate intensity (using aerobics, calisthenics, and weight training), and 10 minutes of stretching. The intensity of the exercise was self-monitored using Borg's scale for perceived exertion, 30 which is widely recommended in pregnancy because of the variations in maternal heart-rate responses to exercise, 28 with a target intensity of 12-14 on the 6-20 scale. Classes were led by physical therapists or students in sports science who were trained and qualitycontrolled by the NFFD team. Attendance was recorded. Although practical and economic considerations limited classes to two per week, participants were encouraged to be physically active at moderate intensity on three additional Excluded from participation and analysis (n = 7)
Miscarriage (n = 3) Twin gestation (n = 0) Pre-pregnancy BMI <17.5 (n = 1) Relocation outside study area (n = 3) Figure 1 . Trial profile. Measurements at 30 weeks of gestation included the glucose challenge test and weight. Measurements at 36 weeks of gestation included weight and the completion of the questionnaire. Four women who moved to another region of the country were considered 'missing completely at random', and were excluded. Fourteen participants in the intervention group withdrew consent to participation, six without receiving any form of intervention, and all prior to the first scheduled follow-up. All 14 consented to an examination of hospital records pertaining to delivery. Seventeen participants in the control arm withdrew consent to participation, all prior to the first scheduled follow-up. Of these, 15 consented to the use of stored data and to an examination of hospital records pertaining to delivery.
days per week, and activity was assessed using questionnaire responses in late pregnancy. Lifestyle recommendations were reinforced with booklets, access to an NFFD internet site, and with an invitation to one cooking class and to an evening meeting, which provided information on the NFFD trial and on the value of regular exercise and a healthy diet in pregnancy. Participants in the control group received routine prenatal care in accordance with Norwegian standards: eight prenatal appointments, including one second-trimester ultrasound examination, with additional care as needed. All pregnant women receive a booklet with advice on prenatal nutrition and physical activity, including recommendations for weight gain based on IOM guidelines. 24 Prenatal care is free of charge and is provided through alternating visits with midwives and doctors.
Measurements
The primary aims of the NFFD trial were to examine whether the intervention resulted in differences in GWG, birthweight of term infants, the proportion of term infants weighing >4000 g, maternal fasting glucose levels at 30 weeks of gestation, maternal percentage of fat at 36 weeks of gestation, and the incidence of operative deliveries. The proportion of newborns of birthweight ≥90th percentile, the proportion of women with elevated 2-hour glucose tolerance tests, the levels of hormones related to glucose metabolism, the incidence of delivery complications, and postpartum weight retention were secondary end points.
Pre-pregnancy weight was self-reported. Participants were weighed at their healthcare clinic upon inclusion in the study using scales that were calibrated at the start of the trial, and also at Sørlandet Hospital at 30 and 36 weeks of gestation (Tanita BC 418, Tokyo, Japan). Pre-pregnancy and inclusion weight were reported in whole kg. Pre-pregnancy weight was compared with measured weight for women included before 13 weeks of gestation (N = 95). No pre-pregnancy weights were discarded for implausibility, defined as a GWG exceeding 9 kg.
31 Participants in the feasibility study self-reported their heights; later participants were measured using a stadiometer (Seca Leicester, Hamburg, Germany). Blood pressure and fetal ultrasound measurements were recorded. Abnormal findings were reported to the antenatal unit for further management.
Participants were weighed on admission to the delivery ward. If missing, the last weight in the prenatal record was recorded along with corresponding date. GWG at term was calculated for women delivering at ≥37 weeks of gestation, with weight recorded within 2 weeks of admission. The rate of GWG was calculated as weight gain from either pre-pregnancy or inclusion weight to last available weight prior to delivery, divided by gestational length at last measurement (for pre-pregnancy weight), or by the interval between date of inclusion and last measurement (for inclusion weight). Compliance with IOM guidelines for GWG was assessed by comparing GWG from pre-pregnancy to term with the upper limit of recommended total gain for each pre-pregnancy BMI category (normal weight, 16 kg; overweight, 11.5 kg; obese, 9 kg). Third-trimester weekly weight gain (difference between weight at first follow-up and last weight measured, divided by interval between measurements) was compared with the upper limit of IOM recommendations for third-trimester weekly weight gain (normal weight, 0.5 kg/week; overweight, 0.33 kg/week; obese, 0.27 kg/ week). The weight, length, head circumference, and Apgar score of the newborn were recorded by delivery ward staff. Weight percentile was calculated according to sex and gestational age using a z-score derived from data in the Medical Birth Registry of Norway, which was determined to be appropriate for the trial population. 32 The proportion of large newborns was calculated using the definitions >4000, >4500 g, and ≥90th percentile. Small for gestational age (SGA) was defined as ≤10th percentile. Hospital records related to pregnancy and delivery were reviewed. Neonatal records were reviewed in case of admission to a neonatal intensive care unit.
Prior to randomisation, fasting blood tests were assessed for evidence of pre-existing diabetes. No participants were excluded on this basis. A glucose tolerance test was performed at 30 weeks of gestation, measuring serum glucose after fasting and at 2 hours after an intake of 75 grams of glucose. Glucose levels ≥7.8 mmol/L at 2 hours were classified as elevated, based on both national and WHO criteria, 33, 34 and participants and their primary care doctors were informed.
Participants in both groups completed questionnaires at inclusion and at 36 weeks of gestation, either electronically (in Norwegian) or in print (in English or Norwegian). The questionnaire had three sections: demographics, diet, and physical activity. Diet was assessed by 43 food-frequency questions analysed using a predetermined score built from ten subscales corresponding to NFFD recommendations. Each subscale was dichotomised using the median value as a cut-off: a value of '0' or '1' was assigned for each subscale, with '1' being the healthier behaviour. The total NFFD diet score thus ranged from 0 to 10, with a higher score indicating healthier behaviour. A detailed description has been published previously. 29 The dietary score has demonstrated acceptable test-retest reliability. 27 Physical activity was assessed with the International Physical Activity Questionnaire, short version (IPAQ-short), which quantifies physical activity during the last 7 days divided into the categories of vigorous intensity, moderate intensity, and walking. 35 Responses from the intervention group included participation in both scheduled and self-initiated physical activity, whereas the control group reported self-initiated physical activity. Responses were scored according to IPAQ analysis algorithms, both as weekly energy expenditure (METs) and as physical activity categories. The IPAQ-short has been validated in a Scandinavian population. 35 
Sample size
As there were scant data on GWG among Norwegian women at the time of planning the trial, power calculations were not based on this variable. We expected a 20% prevalence of newborns with birthweight >4000 g in the control group based on 2005 statistics from the Norwegian birth registry, 36 which were the most recent data available at the time of trial preparation. We determined empirically that a reduction to 10% in the intervention group would be clinically relevant. We calculated that we required 198 women in each study arm to demonstrate statistical significance with a power of 80%. To allow for participant dropout and premature deliveries, we chose to randomise 600 participants.
Statistical analysis
Data were analysed according to the principles of intention to treat (ITT). We compared the study groups regarding continuous outcomes using a Student's t-test after confirming normal distribution. Categorical outcomes were compared using chi-square tests and the results were expressed as mean differences and odds ratios. We used mixed-effects model analysis (linear mixed models), an extension of linear regression that allows for the analysis of repeated measures such as weight without excluding cases with missing data, to assess the influence of age, education, income, occupation, smoking, and pre-pregnancy BMI on the primary outcome of GWG, measured at three time points. Time (gestational week) was modelled as a categorical variable, and the relationship between the levels of the repeated effects was modelled using an unstructured covariance matrix given that time intervals were of different lengths. Thus the covariance of random effects was unstructured and conditional on the random effect, and the within-subject error was assumed to be independent. All selected covariates were treated as fixed effects, whereas time (gestational week) was fitted as a repeated variable. P < 0.05 was considered statistically significant, with no adjustment for multiple comparisons. All tests were two-sided. We used SPSS 21.0 for WINDOWS for all statistical analyses.
Results
The 606 women included in the NFFD trial were equally distributed into intervention and control groups (Figure 1 ). Thirty-one participants withdrew from the study: five women could not/did not wish to exercise; two declined to participate in a control group; two declined testing; and the rest gave no reason for their withdrawal. Among the withdrawals, 29 consented to the use of inclusion data and review of delivery ward records, and 21 consented to the use of all hospital records. The baseline characteristics of the 591 participants included in our analysis were similar in the two groups (Table 1) . There was a trend towards a difference in occupational background, based on a larger proportion of students in the intervention group (35/295, 11.9%) compared with the control group (16/294, 5.4%). Participants were predominantly white, of European descent. There were similar proportions of control and intervention participants from each clinic (P = 0.177). Randomisation was performed at a mean of 16 days after inclusion for both groups. Among women in the intervention arm, 259 (87.5%) received both dietary consultations, 28 (9.5%) received one, and nine (3%) received none. All received access to physical fitness classes and 274 (92.6%) attended at least one class. The number of classes attended varied between 0 and 38, with a median of 14.
Gestational weight gain
Weight recorded at delivery was available for 466/591 (78.8%) women; 114 (19.2%) women had a weight available in the prenatal records (mean 9.8 days before admission) and 11 women had no measurements available after inclusion. The availability of weight at delivery was evenly distributed between the intervention and the control groups (P = 0.904). GWG was calculated using both prepregnancy weight (self-reported) and inclusion weight (measured) as the baseline. Analysis of GWG from prepregnancy to term (n = 557, 94.2%), showed a mean difference between intervention and control group (betweengroup difference) of 1.3 kg (P = 0.009; Table 2 ). Subgroup analyses according to pre-pregnancy BMI category revealed a greater between-group mean difference in GWG with increasing BMI ( Figure S2 ; Table 2 ), but only the normalweight subgroup was of sufficient size to reach statistical significance. Analysing GWG from inclusion to term delivery showed a smaller but significant between-group difference of 0.9 kg (P = 0.043). Here there was no significant intervention effect found when examining subgroups according to pre-pregnancy BMI. The intervention group tended to have a smaller weight increase from pre-pregnancy to inclusion than the control group: 2.2 versus 2.7 kg (mean difference À0.44 kg; 95% confidence interval, 95% CI À0.93 to 0.05 kg; P = 0.079).
The rate of GWG was calculated for all pregnancies using the last available weight measured before delivery (Table 2) . Analysis showed a significantly lower rate of GWG in the intervention group compared with the control group using both pre-pregnancy weight (0.36 kg/week for the intervention group, versus 0.39 kg/week for the control group; mean difference of À0.03 kg/week; 95% CI À0.06 to À0.01 kg/week; P = 0.008) and inclusion weight (0.50 kg/week for the intervention group versus 0.54 kg/ week for the control group; mean difference of À0.03 kg/ week; 95% CI À0.07 to À0.00 kg/week; P = 0.040) as baseline.
A mixed-models analysis using weight measured at gestational weeks 30 and 36, and at term, with pre-pregnancy weight as baseline ( Figure S2 ), revealed a between-group mean difference in GWG of 1.7 kg (95% CI 0.91-2.57 kg; P < 0.001) when adjusted for age, income, education, occu- *Weight at inclusion was missing for eight participants (two in the control group and six in the intervention group). **Glucose was missing for 14 participants (eight in the control group and six in the intervention group). ***C-reactive protein was missing for 18 participants (ten in the control group and eight in the intervention group). ****Two participants failed to complete the questionnaire on socio-economic status. *****Four participants failed to provide information on household income. For analyses not performed on the whole group, the n for each subgroup is presented over the corresponding result. The number of participants with available data is presented to the left, for both the intervention group (i) and the control group (c). Proportions are calculated according to the data available. *Weight measurements for term deliveries (at or within 14 days of admission) missing for 24 participants (12 in the intervention group and 12 in the control group). **Rate of GWG calculated as last available weight before delivery minus pre-pregnancy weight divided by gestational length at time of last measurement. ***Weight at inclusion missing for eight participants (six in the intervention group and two in the control group). ****Rate of GWG calculated as last available weight before delivery minus inclusion weight divided by interval between measurements. *****Exceeding IOM recommendations analysed as total weight gain from pre-pregnancy to term in excess of upper limit of IOM range for corresponding pre-pregnancy BMI group (16 kg for normal weight, 11.5 kg for overweight, and 9 kg for obese). ******Exceeding IOM recommendations analysed as weekly weight gain in third trimester (last available weight minus weight at 30 weeks of gestation, divided by interval between weights, kg/week) in excess of IOM range for corresponding pre-pregnancy BMI group (0.5 kg/week for normal weight, 0.33 kg/week for overweight, and 0.27 kg/week for obese). †P value calculated with Student's t-test. ‡P value calculated with chi-square test.
pation, smoking, and pre-pregnancy BMI category. All covariates except for income and age were statistically significantly associated with GWG (all P < 0.001). The same analysis performed using inclusion weight as baseline demonstrated a between-group mean difference of 1.8 kg (95% CI 0.96-2.58 kg; P < 0.001). All covariates were statistically significant except for income (all P < 0.001).
A secondary analysis of compliance with the IOM guidelines (Table 2 ), comparing total weight gain (between prepregnancy and term) with the upper limit of the IOM ranges, showed a strong trend towards a lower proportion of participants in the intervention group exceeding the guidelines (41.6% of the intervention group versus 50.0% of the control group; OR 0.71; 95% CI 0.51-1.00; P = 0.056). This trend was less evident when the measured rate of weekly weight gain in the third trimester was compared with the IOM recommendations (55.4% exceeded guidelines in the intervention group versus 62.5% in the control group; OR 0.75; 95% CI 0.53-1.04; P = 0.091).
Obstetrical outcomes
The NFFD intervention did not result in a reduction in the proportion of women with gestational diabetes: 12.9% of those tested in the intervention group had an elevated 2-hour glucose tolerance test, versus 9.1% of the control group (OR 1.33; 95% CI 0.77-2.32; P = 0.330; Table 3 ). Record review showed that five intervention participants required insulin for glucose regulation, compared with just one woman in the control group (OR not calculated because of the small numbers). There was no statistically significant difference between groups in the proportion of women with pre-eclampsia (3.4 versus 5.2% for intervention and control groups, respectively; OR 0.65; 95% CI 0.29-1.47; P = 0.31) or premature delivery (5.7 versus 5.8% for intervention and control groups, respectively). The two groups were almost identical in the proportion of women who experienced operative deliveries, including both operative vaginal deliveries (15.9% for intervention group versus 15.6% for control group) and caesarean sections (12.8% for the intervention group versus 12.2% for the control group). There was no difference in the incidence of pre-defined delivery complications: shoulder dystocia (two cases in the intervention group versus three in the control group, OR not calculated because of small numbers), deep perineal lacerations (3.5% in both groups), or postpartum haemorrhage (20.3% for the intervention group versus 19.3% for the control group).
Neonatal outcomes
There was no significant difference between newborns in the two study groups regarding gestational age at delivery, birthweight, length, ponderal index, or head circumference ( Table 3 ). The mean weight for term infants was 3470 g in the intervention group and 3516 g in the control group, with a mean difference of À47 g (95% CI À119 to 25 g; P = 0.20). The proportion of term newborns >4000 g was not significantly lower in the intervention group compared with the control group: 33 (11.8%) versus 39 (14.0%) (OR 0.82; 95% CI 0.50-1.35; P = 0.45). Few NFFD babies were ≥90th percentile: seven (2.4%) in the intervention group versus 11 (3.7%) in the control group. The proportion of SGA infants was equivalent between groups (10.5 versus 9.2% for the intervention and the control groups, respectively). We found no increase in adverse neonatal outcomes as a result of the NFFD intervention.
Lifestyle changes
Intervention and control groups had equivalent dietary scores (mean of 4.92 for both groups) and reported similar weekly energy expenditure (with a mean of 1515 METs for the intervention group versus 1485 METs for the control group; P = 0.828) at inclusion (Table S1 ). At 36 weeks of gestation there was a statistically significant difference between groups in both mean dietary score (5.05 versus 4.60, P = 0.018) and mean reported weekly energy expenditure (1560 versus 1254 METs for the intervention and the control groups, respectively; P = 0.009).
Discussion
Main findings
The NFFD intervention resulted in a modest but significant decrease in GWG in the intervention group compared with the standard prenatal care group. The NFFD intervention did not decrease the incidence of pregnancy complications or operative delivery, and had no effect on fetal weight or neonatal outcomes. NFFD intervention participants reported significantly increased levels of physical activity and improved nutritional habits in late pregnancy, compared with women in the control group.
Strengths and limitations
A major strength of the NFFD trial is its pragmatic design, particularly, in including women attending healthcare clinics rather than examining a highly selected sample recruited through advertisement. ITT analysis further enhanced the pragmatic nature of the trial. Few women discontinued participation and there was little missing data. The blinding of assessors reduced the risk of bias.
The NFFD trial has several limitations. Although there was a high participation rate, recruitment may have been subject to selection bias: our population was older than the mean found for nulliparous women who delivered in southern Norway in 2011 (28.0 versus 26.8 years), 37 and had a higher proportion of highly educated women than was found in a 2014 survey of the region (35.5 versus 25.5%). 38 Furthermore, the population was narrowed to those sufficiently motivated to complete testing before randomisation. The women included in the study were predominantly white, European, and highly educated, with relatively few participants who were overweight or obese, which may limit the reproducibility and external validity of our results. Although it is among the largest trials of its kind to be published, the results demonstrate trends that might have been statistically significant in a larger population. Although we found no differences in SGA and adverse outcomes, the trial had limited power to detect such effects. Combining NFFD results with those of other relevant intervention studies may provide additional information. Self-reported pre-pregnancy weight was used to calculate pre-pregnancy BMI and to define the baseline in some analyses. Although it has demonstrated strong validity in earlier GWG studies, 14, 39 self-reported weight remains subjective. Registering pre-pregnancy and inclusion weight in whole kg may have made small changes in weight difficult to measure. The degree of exertion during exercise classes was subjectively measured using Borg's scale, and levels of dietary compliance and physical activity were self-reported using questionnaires. Although diet is difficult to measure objectively, the use of accelerometers might have allowed for a more objective evaluation of physical activity.
As a result of individual randomisation, women living in close proximity and attending the same clinic were often in different trial groups. Midwives at the participating clinics were also informed about the purpose of the trial. It is therefore possible that control participants were influenced to some extent, and that analysis underestimates the effect of intervention. Alternately, we can conjecture that the NFFD intervention could have demonstrated a greater effect had the intervention elements been stronger, with more intensive activity sessions or more restrictive dietary advice, for example with calorie limitations.
Interpretation
Gestational weight gain The NFFD intervention resulted in a 0.9 kg reduction in GWG using objectively measured weight and unadjusted calculations, and a slightly greater effect using self-reported pre-pregnancy weights. Although subgroups based on prepregnancy BMI category had limited statistical power to demonstrate effect of the intervention, the results suggest that the NFFD intervention resulted in lower GWG for women in all BMI subgroups. Our findings correspond well with the two trials to date that have compared a combination of dietary counselling and supervised exercise groups with standard prenatal care: that of Hui from Canada and Vinter from Denmark, both of which found a 1.1-1.2 kg reduction in GWG as a result of intervention. 22, 23 A large proportion of NFFD participants exceeded the IOM recommendations for GWG, consistent with recently published data on self-reported GWG for 29 931 nulliparous Norwegian women. 40 NFFD intervention participants received individual information about recommended GWG early in the study, but were not given any feedback when they were later measured, as assessors were blinded to group allocation. Ronnberg et al. 41 have recently reported a significant reduction in GWG using personalised weight graphs and regular weight monitoring. Combining the NFFD intervention with interim evaluation of weight gain might have further improved IOM compliance. The intervention effect is expressed as an odds ratio (OR) with 95% confidence interval (95% CI) and P value calculated with the chi-square test, or as a mean difference with 95% CI and P value calculated with Student's t-test. (À, not calculated because of small numbers). *Glucose tolerance test not performed for the following participants: 29 withdrew from study; two delivered preterm; and 12 failed to complete because of vomiting or other complication. One test (control) discarded because of concurrent influenza and elevated C-reactive protein (CRP); n = 275 (i), 272 (c). **Data based on complete medical record review. Eight participants (three in the intervention group and five in the control group) not included, who withdrew from the study and gave consent to a review of maternity ward records alone; n = 293 (i), 290 (c). ***Data based on review of maternity ward records for all participants. ****Term gestations: n = 279 (i), 278 (c). *****Ponderal index = 100 9 weight/length³. ******Birthweight percentile calculated according to sex and gestational age, based on data from the Medical Birth Registry of Norway. ‡NICU, Neonatal Intensive Care Unit.
Obstetrical outcomes
The NFFD intervention reduced GWG without a corresponding reduction in obstetric complications. This is consistent with the meta-analysis of Thangaratinam et al., which showed that interventions combining dietary and physical activity elements, usually in the form of counselling, reduced GWG without affecting the risk of pregnancy complications or caesarean section. 15 The more recent UK Pregnancies Better Eating and Activity Trial (UPBEAT) study, a large, multi-centre study of behavioural intervention, showed the same outcome pattern. 26 The use of supervised exercise groups in the NFFD trial did not result in a measurably greater effect; however, the NFFD trial had limited power to detect changes in preeclampsia and preterm delivery risk, and results show trends that may have been significant in a much larger group. Observational studies have found that the development of gestational diabetes is closely linked with weight gain and fat deposition during the first trimester. 8, 9 The NFFD intervention was initiated in the second trimester, perhaps too late to affect the complex metabolic processes regulating the development of glucose intolerance. Future studies of lifestyle interventions should focus on early pregnancy, or on the inter-pregnancy period, 42 particularly for the women who are overweight or obese, who are most at risk for pregnancy complications. To date, dietary interventions have shown the greatest effect on obstetrical outcomes. 15 Research is needed to define which elements are of most consequence: specific dietary patterns; calorie restriction; micronutrient availability; or carbohydrate, fat, and fibre content.
Neonatal outcomes
We failed to detect a decrease in the proportion of large neonates. This is consistent with the findings of several systemic reviews of GWG interventions, which have reported little or no effect on fetal weight and the proportion of large newborns, regardless of the type of intervention. 15, 16, 20 The NFFD trial had fewer babies of >4000 g than had been predicted: 14% rather than the anticipated 20% in the control group. The proportion of macrosomic infants decreased yearly in Norway from 2005 to 2012, when 17.2% of infants were ≥4000 g. 43 Including only first-born infants in the trial may explain further reductions. To achieve a power of 80% to demonstrate statistical significance with the difference in proportion of large newborns seen here, over 1000 women would be needed in each arm of the study. Of note, the LIMIT trial from Australia demonstrated a small but statistically significant decrease in newborns >4000 g in a population of 2152 women who were obese, without change in GWG. 25 
Lifestyle changes
Questionnaire responses suggest that both intervention elements have created behaviour change. In late pregnancy, the intervention group had a higher diet score compared with the control group, and an increased physical activity level compared with their baseline at inclusion. The control group reported decreased physical activity in late pregnancy, corresponding well with earlier findings that most women decrease or stop exercising by the third trimester. 44 Intervention group responses are plausible given the measurable result of decreased GWG. Maternal dietary and physical activity patterns affect the intrauterine environment, which may in turn affect the child's later health. 3, 45, 46 Improving the new mother's habits may also positively influence the lifestyle of the new family.
47,48
Conclusion
The NFFD lifestyle intervention did not demonstrate any measurable effect on the proportion of large newborns or the incidence of obstetrical complications, but did result in a significant reduction in GWG.
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